One example is miR-182, which downregulates the expression of BRCA1. Moreover, overexpression of this miRNA in BC cells was demonstrated to increase the sensitivity to poly-ADP-ribose-polymerase1 (PARP1) inhibitors (PARPi). This evidence concerns the gene BRCA1 and breast cancer.